Production (Stage)
Trinity Biotech plc
TRIB
$0.64
$0.00590.93%
NASDAQ
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | 09/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -208.22% | -12.84% | 45.42% | 24.86% | -777.14% |
| Total Depreciation and Amortization | -7.39% | -68.39% | -26.87% | -69.22% | -4.12% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 349.73% | 60.92% | -67.24% | -52.37% | 533.55% |
| Change in Net Operating Assets | 180.36% | 229.47% | 37.52% | -1,620.92% | 108.61% |
| Cash from Operations | 1,284.30% | 75.10% | -86.78% | -789.94% | -60.16% |
| Capital Expenditure | 37.20% | 52.32% | 47.37% | 60.12% | -17.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -302.34% | -649.39% | 3.17% | 24.43% | 40.51% |
| Cash from Investing | -207.07% | -111.37% | 21.64% | 33.08% | 32.41% |
| Total Debt Issued | -- | 4,321.09% | -100.00% | -- | -- |
| Total Debt Repaid | -19.82% | 94.33% | 7.50% | 16.52% | 5.79% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 93.79% | 33.13% | -2.03% | -10.19% | -- |
| Cash from Financing | 202.38% | 129.10% | -25.66% | -2.49% | -226.72% |
| Foreign Exchange rate Adjustments | 41.77% | -225.58% | -578.79% | 107.82% | -16.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 190.54% | -104.56% | -280.18% | -149.05% | -180.12% |